D

Diagnostyka SA
WSE:DIA

Watchlist Manager
Diagnostyka SA
WSE:DIA
Watchlist
Price: 168.9 PLN 2.36% Market Closed
Market Cap: zł5.7B

Wall St Price Targets

DIA Price Targets Summary
Diagnostyka SA

Wall Street analysts forecast DIA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DIA is 202.37 PLN with a low forecast of 177.76 PLN and a high forecast of 225.75 PLN.

Lowest Forecast
Price Target
177.76 PLN
5% Upside
Average Forecast
Price Target
202.37 PLN
20% Upside
Highest Forecast
Price Target
225.75 PLN
34% Upside
Diagnostyka SA Competitors:
Price Targets
VNET
Vianet Group PLC
227% Upside
TRI
Thomson Reuters Corp
-16% Downside

Revenue
Forecast

19% / Year
Past Growth
9% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
19% / Year
Past Growth
9% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 3 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 8 years is 9%.

Gross Profit
Forecast

27% / Year
Past Growth
10% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
27% / Year
Past Growth
10% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 3 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 5 years is 10%.

Operating Income
Forecast

14% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
14% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 3 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 8 years is 12%.

Pre-Tax Income
Forecast

13% / Year
Past Growth
29% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
13% / Year
Past Growth
29% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 3 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 2 years is 29%.

Net Income
Forecast

15% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
15% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 3 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 5 years is 12%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is DIA's stock price target?
Price Target
202.37 PLN

According to Wall Street analysts, the average 1-year price target for DIA is 202.37 PLN with a low forecast of 177.76 PLN and a high forecast of 225.75 PLN.

What is the Revenue forecast for Diagnostyka SA?
Projected CAGR
9%

Over the last 3 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 8 years is 9%.

What is the Gross Profit forecast for Diagnostyka SA?
Projected CAGR
10%

Over the last 3 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 5 years is 10%.

What is the Operating Income forecast for Diagnostyka SA?
Projected CAGR
12%

Over the last 3 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 8 years is 12%.

What is the Pre-Tax Income forecast for Diagnostyka SA?
Projected CAGR
29%

Over the last 3 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 2 years is 29%.

What is the Net Income forecast for Diagnostyka SA?
Projected CAGR
12%

Over the last 3 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 5 years is 12%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett